China Tightens Grip on Solar, Drones, and Drugmaking Technology Amid Rare Earth Dominance

China is expanding its strategic leverage beyond rare earth minerals to control critical technologies in solar energy, drones, and pharmaceuticals, making it increasingly difficult for rival nations to reduce dependence on Chinese manufacturing. The move signals a broader industrial strategy that leverages China's production scale and supply chain integration. Key sectors affected include photovoltaic cells, unmanned aerial vehicles, and active pharmaceutical ingredients, where Chinese firms hold significant global market share. This development matters because it could reshape global supply chains, raise costs for Western companies, and intensify geopolitical competition over advanced manufacturing. As countries seek to diversify away from China, Beijing's tightening grip on these technologies underscores the challenge of decoupling from the world's factory. The long-term impact may accelerate investment in domestic capabilities among rivals, but near-term dependencies remain stark.